Test run for China’s new cancer therapy
Print Edition
China’s first accelerator-based boron neutron capture therapy equipment is expected to be used for radiation treatment in 2019, its developers said.
The equipment was jointly developed by Nanjing University of Aeronautics and Astronautics and several companies. It is currently in the test phase.
BNCT is a targeted radiation cancer therapy in which neutron beams destroy only the boron compound-bearing tumor without causing radiation damage to the neighboring normal tissue. It is less traumatic than current treatments and has fewer side effects.
“The biggest challenge in the development and application of BNCT is the neutron source,” said Liu Yuanhao, a nuclear science and engineering professor at the university.
Liu said that neutrons can be produced either through a reactor or an accelerator. But due to high costs and safety issues, it is difficult to build reactors in hospitals, while “using an accelerator is cheaper, safer and the neutron beams are easily controlled.”
Currently, countries such as Japan, Finland, Italy, Russia, and the United States are the frontrunners in the clinical studies of BNCT, he added.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
